TE_27893
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | MSTA |
|---|---|
| TE superfamily | MaLR |
| TE class | LTR |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 205.70 |
| Counts of samples | TCGA_tumor:364; TCGA_normal:1; GTEx:0 |
| TSS | chr14(+):83638975 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_27893.1 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639395,83646544,83646654,83666131,83666151 |
| teRNA_27893.2 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639395,83646544,83646654,83658423,83658443 |
| teRNA_27893.3 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639395,83646544,83646654,83651221,83651241 |
| teRNA_27893.4 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639439,83646544,83646654,83658423,83658443 |
| teRNA_27893.5 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639439,83646544,83646654,83666131,83666151 |
| teRNA_27893.6 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639395,83646544,83646654,83651221,83651467,83658423,83658443 |
| teRNA_27893.7 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639395,83646544,83646654,83651221,83651467,83666131,83666151 |
| teRNA_27893.8 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639395,83646544,83646654,83676768,83676788 |
| teRNA_27893.9 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639395,83646544,83646654,83651221,83651467,83651818,83651838 |
| teRNA_27893.10 | - | Intergenic | Non-coding | Non-coding | chr14(+):83638976,83639082,83639300,83639395,83646544,83646654,83832275,83832309,83841716,83841745,83867288,83867308 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
